Filing
Spy
Filing
Spy
Home
About
VRDN
Viridian Therapeutics Inc
Biotechnology company developing treatments for serious and rare diseases
CUSIP: 92790C104
Healthcare
US
1 holder
Ownership
Activity
2025 Q3
1 of 8 quarters
Total Value
$47.75M
Total Shares
2.21M
Net Share Change
-44.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$47.75M
2.21M
0.6%
TRIM
-44.3K
(-2.0%)
Maverick Capital
$47.75M
2.21M shares
TRIM
-44.3K
(-2.0%)
VRDN — Viridian Therapeutics Inc - FilingSpy